斑蝥素的抗肿瘤作用研究。 - Suppr

Suppr

超能文献

Studies on antitumor actions of cantharidin.

作者信息

Chen R T, Hua Z, Yang J L, Han J X, Zhang S Y, Lü F L, Xü B

出版信息

Chin Med J (Engl). 1980 Mar;93(3):183-7.

PMID:6766849

Abstract

摘要

相似文献

Studies on antitumor actions of cantharidin.斑蝥素的抗肿瘤作用研究。

Chin Med J (Engl). 1980 Mar;93(3):183-7.

[A study on antitumor chemotherapeutic agents--synthesis of N-cantharidine derivatives (author's transl)].抗肿瘤化疗药物的研究——N-斑蝥素衍生物的合成（作者译）

Yao Xue Xue Bao. 1981 Oct;16(10):784-6.

[Studies on antitumor chemotherapeutic agents. II. Synthesis of cantharidine derivatives and analogues].[抗肿瘤化疗药物的研究。II. 斑蝥素衍生物及类似物的合成]

Yao Xue Xue Bao. 1983 Oct;18(10):752-9.

Modulation of antitumor immunity of tumor-bearing mice with low-dose cyclophosphamide.低剂量环磷酰胺对荷瘤小鼠抗肿瘤免疫的调节作用

J Surg Res. 1996 Oct;65(2):139-44. doi: 10.1006/jsre.1996.0356.

[On the antitumor activity of leukoantocyanidines and catechins].

Vopr Onkol. 1966 Apr;12(4):61-4.

Studies on the effect of phytohemagglutinin on ascites tumor in mice.植物血凝素对小鼠腹水瘤作用的研究。

Isr J Med Sci. 1971 Jan;7(1):83-9.

[A study of antitumor chemotherapeutic agents -synthesis of cantharidine derivatives (author's transl)].

Yao Xue Xue Bao. 1980 May;15(5):271-7.

[The antitumor effect and a pharmacological study of disodium cantharidate (author's transl)].斑蝥酸钠二钠的抗肿瘤作用及药理学研究（作者译）

Zhonghua Zhong Liu Za Zhi. 1980;2(2):96-100.

[Correction of anti-tumor immunity by beta-carotene during experimental chemotherapy of malignant neoplasms].[恶性肿瘤实验性化疗期间β-胡萝卜素对抗肿瘤免疫的纠正作用]

Biull Eksp Biol Med. 1994 Sep;118(9):295-7.

Cooperation between cyclophosphamide tumoricidal activity and host antitumor immunity in the cure of mice bearing large MOPC-315 tumors.环磷酰胺的杀肿瘤活性与宿主抗肿瘤免疫在治愈携带大的MOPC - 315肿瘤小鼠中的协同作用。

Cancer Res. 1981 Jun;41(6):2163-7.

引用本文的文献

Pharmacological mechanism of mylabris in the treatment of leukemia based on bioinformatics and systematic pharmacology.基于生物信息学和系统药理学的斑蝥治疗白血病的作用机制。

Bioengineered. 2021 Dec;12(1):3229-3239. doi: 10.1080/21655979.2021.1943110.

Anticancer Attributes of Cantharidin: Involved Molecular Mechanisms and Pathways.斑蝥素的抗癌特性：涉及的分子机制和途径。

Molecules. 2020 Jul 19;25(14):3279. doi: 10.3390/molecules25143279.

Breaking Glucose Transporter 1/Pyruvate Kinase M2 Glycolytic Loop Is Required for Cantharidin Inhibition of Metastasis in Highly Metastatic Breast Cancer.打破葡萄糖转运蛋白1/丙酮酸激酶M2糖酵解循环是斑蝥素抑制高转移性乳腺癌转移所必需的。

Front Pharmacol. 2019 May 24;10:590. doi: 10.3389/fphar.2019.00590. eCollection 2019.

Comparative assessment of therapeutic safety of norcantharidin, N-farnesyloxy-norcantharimide, and N-farnesyl-norcantharimide against Jurkat T cells relative to human normal lymphoblast: A quantitative pilot study.相对于人正常淋巴母细胞，去甲斑蝥素、N-法尼基氧基去甲斑蝥酰亚胺和N-法尼基去甲斑蝥酰亚胺对Jurkat T细胞治疗安全性的比较评估：一项定量初步研究。

Medicine (Baltimore). 2016 Aug;95(31):e4467. doi: 10.1097/MD.0000000000004467.

N-Farnesyloxy-norcantharimide inhibits progression of human leukemic Jurkat T cells through regulation of mitogen-activated protein kinase and interleukin-2 production.N-法尼基氧基去甲斑蝥素通过调节丝裂原活化蛋白激酶和白细胞介素-2的产生来抑制人白血病Jurkat T细胞的增殖。

Anticancer Drugs. 2015 Nov;26(10):1034-42. doi: 10.1097/CAD.0000000000000284.

Synthesis of novel lipophilic N-substituted norcantharimide derivatives and evaluation of their anticancer activities.新型亲脂性 N-取代去甲斑蝥素衍生物的合成及抗癌活性评价。

Molecules. 2014 May 26;19(6):6911-28. doi: 10.3390/molecules19066911.

Immune adjuvants for chemotherapy or radiotherapy in the 9L rat brain tumor model.9L大鼠脑肿瘤模型中用于化疗或放疗的免疫佐剂。

J Neurooncol. 1993 Feb;15(2):113-23. doi: 10.1007/BF01053932.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验